Stem Cell Therapy and Tissue Engineering
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 1186
Special Issue Editor
2. Department of Chemistry, Faculty of Sciences, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100 Canakkale, Turkey
Interests: natural polymers; glycosaminoglycans; sugar alcohols; carbohydrates; polyphenolics; amino acids; peptides; nano/microparticles; antioxidant; anti-inflammatory; antimicrobial activity; ROS-scavenging effect; antiviral; antifungal; biocidal; anticancer; controlled release; drug delivery; biocompatible; blood compatible; surface; (bio)interfaces; smart surfaces; surface modification; superhydrophobic; super hydrophilic; (bio)sensor; theragnostic, biopolymeric MRI agents; injectables biopolymeric materials; hydrogel; cryogel; microgel; nanogels; super porous materials; pharmacology; wound healing; wound dressing; medical device; tissue engineering; stimuli-responsive structures; wearables; artificial skin; shape memory polymers; injectable materials; biodegradable active agent carriers; carbon particle; quantum dots, carbon dots, graphene dots, g-C3N4; lubricant, intra-articular and joints injection materials; cosmetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent developments in stem cell therapy (SCT) or regenerative medicine, especially in the fields of various chronic and acute disease treatments and organs associated with human health, are steadily increasing. It has been accepted that the therapeutic utilization of stem cells (SCs) or their derivatives not only enhances the repair and/or replaces the malfunctioned or damaged tissue but also improves quality of life. SCs can be engineered into specific types of cells and organs, e.g., skin cells, blood cells, nerve cells, muscle cells and so on, that can be implanted to contribute to the repair of damaged tissue and organs. SCT application is not limited to cardiovascular, ophthalmological, neurological, orthopedical, and dental therapy, but is also used in cancer therapy as well as in testing new drugs. ALthough there are many types of SCs, the two main types depending on their differential potential are pluripotent stem cells (PSCs), which are embryonic SCs and induced pluripotent SCs, and tissue-specific (adult) SCs, which are also considered multipotent SCs and can only differentiate into specific cell types within their tissue of origin.
The materials employed in SC research and therapy are a critical aspect of tissue engineering. These materials can be synthetic or natural in origin or a combination of both or composites with some inorganic components, biocompatible and/or biodegradable templates, or scaffolds that host the SCs and the required essential additives. These materials are generally hydrogels, cryogels, and porous networks that can be derived from a variety of biomaterials affording structural support and mimicking the extracellular matrix. The presence of growth factors, small proteins (cytokines), and other additives along with SCs within tissue engineering materials can steer and guide the differentiation and proliferation of SCs into the desired cell types. Therefore, advanced versatile biomaterials for tissue engineering applications of SCs are of paramount significance for the success of SCT.
This Special Issue primarily focuses on SC proliferation and differentiation for specific cell development and production within biomaterials used as scaffolds, and the nature and importance of these templates used in SC tissue engineering will be emphasized. The SCT for the treatment of various diseases, cancer therapy, and drug testing are within the scope of this Special Issue.
Dr. Nurettin Sahiner
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stem cells
- stem cell therapy
- stem cell cancer therapy
- hydrogels/cryogels
- porous network biomaterials
- tissue engineering
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
